Targeted Therapy for Breast Cancer Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1406789 No. of Pages: 68 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Breast cancer is a disease in which cells in the breast grow out of control. There are different kinds of breast cancer.
This report contains market size and forecasts of Targeted Therapy for Breast Cancer in Global, including the following market information:
Global Targeted Therapy for Breast Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Targeted Therapy for Breast Cancer market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Brand Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Targeted Therapy for Breast Cancer include Eli Lilly and Company, Roche, Merck & Co., Novartis, Pfizer, Merck KGaA, Astellas, Janssen Biotech and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Targeted Therapy for Breast Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Targeted Therapy for Breast Cancer Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Targeted Therapy for Breast Cancer Market Segment Percentages, by Type, 2021 (%)
Brand Drugs
Generic Drug
Global Targeted Therapy for Breast Cancer Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Targeted Therapy for Breast Cancer Market Segment Percentages, by Application, 2021 (%)
Hospital
Retail Pharmacy
Other
Global Targeted Therapy for Breast Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Targeted Therapy for Breast Cancer Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Targeted Therapy for Breast Cancer revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Targeted Therapy for Breast Cancer revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly and Company
Roche
Merck & Co.
Novartis
Pfizer
Merck KGaA
Astellas
Janssen Biotech
Bristol-Myers Squibb
Gilead Sciences
1 Introduction to Research & Analysis Reports
1.1 Targeted Therapy for Breast Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Targeted Therapy for Breast Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Targeted Therapy for Breast Cancer Overall Market Size
2.1 Global Targeted Therapy for Breast Cancer Market Size: 2021 VS 2028
2.2 Global Targeted Therapy for Breast Cancer Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Targeted Therapy for Breast Cancer Players in Global Market
3.2 Top Global Targeted Therapy for Breast Cancer Companies Ranked by Revenue
3.3 Global Targeted Therapy for Breast Cancer Revenue by Companies
3.4 Top 3 and Top 5 Targeted Therapy for Breast Cancer Companies in Global Market, by Revenue in 2021
3.5 Global Companies Targeted Therapy for Breast Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Targeted Therapy for Breast Cancer Players in Global Market
3.6.1 List of Global Tier 1 Targeted Therapy for Breast Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Targeted Therapy for Breast Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Targeted Therapy for Breast Cancer Market Size Markets, 2021 & 2028
4.1.2 Brand Drugs
4.1.3 Generic Drug
4.2 By Type - Global Targeted Therapy for Breast Cancer Revenue & Forecasts
4.2.1 By Type - Global Targeted Therapy for Breast Cancer Revenue, 2017-2022
4.2.2 By Type - Global Targeted Therapy for Breast Cancer Revenue, 2023-2028
4.2.3 By Type - Global Targeted Therapy for Breast Cancer Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Targeted Therapy for Breast Cancer Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Targeted Therapy for Breast Cancer Revenue & Forecasts
5.2.1 By Application - Global Targeted Therapy for Breast Cancer Revenue, 2017-2022
5.2.2 By Application - Global Targeted Therapy for Breast Cancer Revenue, 2023-2028
5.2.3 By Application - Global Targeted Therapy for Breast Cancer Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Targeted Therapy for Breast Cancer Market Size, 2021 & 2028
6.2 By Region - Global Targeted Therapy for Breast Cancer Revenue & Forecasts
6.2.1 By Region - Global Targeted Therapy for Breast Cancer Revenue, 2017-2022
6.2.2 By Region - Global Targeted Therapy for Breast Cancer Revenue, 2023-2028
6.2.3 By Region - Global Targeted Therapy for Breast Cancer Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Targeted Therapy for Breast Cancer Revenue, 2017-2028
6.3.2 US Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.3.3 Canada Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.3.4 Mexico Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Targeted Therapy for Breast Cancer Revenue, 2017-2028
6.4.2 Germany Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.4.3 France Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.4.4 U.K. Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.4.5 Italy Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.4.6 Russia Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.4.7 Nordic Countries Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.4.8 Benelux Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Targeted Therapy for Breast Cancer Revenue, 2017-2028
6.5.2 China Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.5.3 Japan Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.5.4 South Korea Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.5.5 Southeast Asia Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.5.6 India Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Targeted Therapy for Breast Cancer Revenue, 2017-2028
6.6.2 Brazil Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.6.3 Argentina Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Targeted Therapy for Breast Cancer Revenue, 2017-2028
6.7.2 Turkey Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.7.3 Israel Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.7.4 Saudi Arabia Targeted Therapy for Breast Cancer Market Size, 2017-2028
6.7.5 UAE Targeted Therapy for Breast Cancer Market Size, 2017-2028
7 Players Profiles
7.1 Eli Lilly and Company
7.1.1 Eli Lilly and Company Corporate Summary
7.1.2 Eli Lilly and Company Business Overview
7.1.3 Eli Lilly and Company Targeted Therapy for Breast Cancer Major Product Offerings
7.1.4 Eli Lilly and Company Targeted Therapy for Breast Cancer Revenue in Global Market (2017-2022)
7.1.5 Eli Lilly and Company Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Targeted Therapy for Breast Cancer Major Product Offerings
7.2.4 Roche Targeted Therapy for Breast Cancer Revenue in Global Market (2017-2022)
7.2.5 Roche Key News
7.3 Merck & Co.
7.3.1 Merck & Co. Corporate Summary
7.3.2 Merck & Co. Business Overview
7.3.3 Merck & Co. Targeted Therapy for Breast Cancer Major Product Offerings
7.3.4 Merck & Co. Targeted Therapy for Breast Cancer Revenue in Global Market (2017-2022)
7.3.5 Merck & Co. Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Targeted Therapy for Breast Cancer Major Product Offerings
7.4.4 Novartis Targeted Therapy for Breast Cancer Revenue in Global Market (2017-2022)
7.4.5 Novartis Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Targeted Therapy for Breast Cancer Major Product Offerings
7.5.4 Pfizer Targeted Therapy for Breast Cancer Revenue in Global Market (2017-2022)
7.5.5 Pfizer Key News
7.6 Merck KGaA
7.6.1 Merck KGaA Corporate Summary
7.6.2 Merck KGaA Business Overview
7.6.3 Merck KGaA Targeted Therapy for Breast Cancer Major Product Offerings
7.6.4 Merck KGaA Targeted Therapy for Breast Cancer Revenue in Global Market (2017-2022)
7.6.5 Merck KGaA Key News
7.7 Astellas
7.7.1 Astellas Corporate Summary
7.7.2 Astellas Business Overview
7.7.3 Astellas Targeted Therapy for Breast Cancer Major Product Offerings
7.7.4 Astellas Targeted Therapy for Breast Cancer Revenue in Global Market (2017-2022)
7.7.5 Astellas Key News
7.8 Janssen Biotech
7.8.1 Janssen Biotech Corporate Summary
7.8.2 Janssen Biotech Business Overview
7.8.3 Janssen Biotech Targeted Therapy for Breast Cancer Major Product Offerings
7.8.4 Janssen Biotech Targeted Therapy for Breast Cancer Revenue in Global Market (2017-2022)
7.8.5 Janssen Biotech Key News
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Corporate Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Targeted Therapy for Breast Cancer Major Product Offerings
7.9.4 Bristol-Myers Squibb Targeted Therapy for Breast Cancer Revenue in Global Market (2017-2022)
7.9.5 Bristol-Myers Squibb Key News
7.10 Gilead Sciences
7.10.1 Gilead Sciences Corporate Summary
7.10.2 Gilead Sciences Business Overview
7.10.3 Gilead Sciences Targeted Therapy for Breast Cancer Major Product Offerings
7.10.4 Gilead Sciences Targeted Therapy for Breast Cancer Revenue in Global Market (2017-2022)
7.10.5 Gilead Sciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com